Dashboard
Manage Tickers

TNYA Tenaya Therapeutics, Inc.

Nasdaq tenayatherapeutics.com


$ 1.37 $ -0.17 (-11.04 %)    

Thursday, 13-Nov-2025 16:05:04 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 1.37
$ 1.53
$ 1.35 x 855
$ 1.54 x 120
-- - --
$ 0.36 - $ 4.01
3,229,704
na
228.11M
$ 2.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-10-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-18-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-23-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 09-08-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-tenaya-therapeutics-maintains-9-price-target
Chardan Capital Maintains Buy on Tenaya Th...
11/10/2025 20:12:12

Chardan Capital analyst Geulah Livshits maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $9 price target.

tenaya-therapeutics-q3-eps-012-beats-015-estimate
Tenaya Therapeutics Q3 EPS $(0.12) Beats $...
11/10/2025 12:15:24

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $...

reported-saturday-tenaya-therapeutics-reports-tn-201-well-tolerated-at-3e13-and-6e13-vgkg-with-managed-immunogenicity-and-no-dose-limiting-toxicities-in-mypeak-1
Reported Saturday, Tenaya Therapeutics Rep...
11/10/2025 09:08:38

MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovas...

tenaya-therapeutics-says-expects-no-impact-on-tn-201-timelines-from-hold-says-working-to-resolve-clinical-hold-and-resume-dosing
Tenaya Therapeutics Says Expects No Impact...
11/07/2025 21:27:01

fda-places-clinical-hold-on-tenaya-therapeutics-tn-201-trial-requests-protocol-amendment-for-patient-monitoring-and-immunosuppression-management
FDA Places Clinical Hold On Tenaya Therape...
11/07/2025 21:26:07

The U.S. Food and Drug Administration ("FDA") has placed a clinical hold on MyPEAKTM-1,Tenaya Therapeutics, Inc.'s ...

tenaya-therapeutics-to-give-two-late-breaking-oral-presentations-at-the-american-heart-association-2025-scientific-sessions-taking-place-november-7-10-2025
Tenaya Therapeutics To Give Two Late-break...
11/04/2025 22:39:21

Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

top-4-biotech-stocks-set-for-a-breakout-momentum-scores-surge
Top 4 Biotech Stocks Set For A Breakout: M...
09/08/2025 09:59:39

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Ed...

hc-wainwright--co-reiterates-buy-on-tenaya-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Tena...
09/02/2025 10:51:49

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $5 pr...

reported-sunday-tenaya-highlights-urgent-need-for-disease-modifying-approaches-in-pediatric-mybpc3-associated-hcm-based-on-myclimb-interim-findings
Reported Sunday, Tenaya Highlights Urgent ...
09/02/2025 07:42:02

Largest Noninterventional Natural History Study of People Under 18 with MYBPC3-associated HCM with More than 200 Participants93...

hc-wainwright--co-reiterates-buy-on-tenaya-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Tena...
08/27/2025 10:15:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $5 pr...

chardan-capital-maintains-buy-on-tenaya-therapeutics-maintains-9-price-target
Chardan Capital Maintains Buy on Tenaya Th...
08/07/2025 12:50:49

Chardan Capital analyst Geulah Livshits maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $9 price target.

tenaya-therapeutics-q2-eps-014-beats-017-estimate
Tenaya Therapeutics Q2 EPS $(0.14) Beats $...
08/06/2025 21:13:47

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $...

tenaya-therapeutics-completes-enrollment-in-mypeak-1-trial-for-hcm-and-initiates-ridge-1-trial-for-arvc-with-dsmb-endorsements
Tenaya Therapeutics Completes Enrollment I...
07/30/2025 12:36:30

Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Comp...

chardan-capital-maintains-buy-on-tenaya-therapeutics-maintains-9-price-target
Chardan Capital Maintains Buy on Tenaya Th...
05/09/2025 10:53:51

Chardan Capital analyst Geulah Livshits maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $9 price target.

tenaya-therapeutics-q1-eps-024-misses-020-estimate
Tenaya Therapeutics Q1 EPS $(0.24) Misses ...
05/07/2025 21:26:32

Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of...

hc-wainwright--co-reiterates-buy-on-tenaya-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Tena...
04/25/2025 11:36:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $5 pr...

tenaya-therapeutics-reveals-interim-data-from-ridge-natural-history-and-seroprevalence-study-of-adults-with-pkp2-associated-arvc-at-heart-rhythm-2025
Tenaya Therapeutics Reveals Interim Data f...
04/24/2025 18:23:13

hc-wainwright--co-reiterates-buy-on-tenaya-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Tena...
03/31/2025 14:38:23

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $5 pr...

tenaya-therapeutics-announces-late-breaker-presentation-of-new-data-from-mypeak-1-phase-1b2-clinical-trial-of-tn-201-at-american-college-of-cardiology-annual-meeting
Tenaya Therapeutics Announces Late Breaker...
03/31/2025 14:06:40

TN-201 Has Been Well Tolerated at 3E13 vg/kg DoseNew Biopsy Data Reaffirm Robust Transduction and RNA Expression with TN-201; R...

tenaya-therapeutics-approves-restructuring-plan-restructuring-plan-to-reduce-cash-expenses-restructuring-plan-to-extend-cash-runway-into-h2-2026-to-reduce-workforce-under-restructuring-plan-to-incur-16m-27m-in-restructuring-charges-expects-to-recognize-charges-by-q3-2025
Tenaya Therapeutics Approves Restructuring...
03/28/2025 20:44:10

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION